Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Newton

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 1, 2024
In vivo mRNA expression of a multi-mechanistic mAb combination protects against Staphylococcus aureus infectionChristine Tkaczyk, Michael Newton, Mun Mun Patnaik, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|January 9, 2018
Mutant cartilage oligomeric matrix protein (COMP) compromises bone integrity, joint function and the balance between adipogenesis and osteogenesisFrancoise Coustry, Karen L Posey, Tristan Maerz, et al.
Tissue Engineering. Part A|August 31, 2019
3D-Printed Ceramic-Demineralized Bone Matrix Hyperelastic Bone Composite Scaffolds for Spinal FusionJ Adam Driscoll, Ryan Lubbe, Adam E Jakus, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 21, 2021
Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC-an Update From the PACIFIC TrialCorinne Faivre-Finn, David Vicente, Takayasu Kurata, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2022
Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung CancerDavid R Spigel, Corinne Faivre-Finn, Jhanelle E Gray, et al.
NPJ Vaccines|December 13, 2025
Immunogenicity and efficacy of an mRNA vaccine expressing a virus-like particle spike antigen against SARS-CoV-2Jason P Laliberte, Yingyun Cai, Tara Kenny, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 1, 2024
In vivo mRNA expression of a multi-mechanistic mAb combination protects against Staphylococcus aureus infectionChristine Tkaczyk, Michael Newton, Mun Mun Patnaik, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|January 9, 2018
Mutant cartilage oligomeric matrix protein (COMP) compromises bone integrity, joint function and the balance between adipogenesis and osteogenesisFrancoise Coustry, Karen L Posey, Tristan Maerz, et al.
Tissue Engineering. Part A|August 31, 2019
3D-Printed Ceramic-Demineralized Bone Matrix Hyperelastic Bone Composite Scaffolds for Spinal FusionJ Adam Driscoll, Ryan Lubbe, Adam E Jakus, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 21, 2021
Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC-an Update From the PACIFIC TrialCorinne Faivre-Finn, David Vicente, Takayasu Kurata, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2022
Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung CancerDavid R Spigel, Corinne Faivre-Finn, Jhanelle E Gray, et al.
NPJ Vaccines|December 13, 2025
Immunogenicity and efficacy of an mRNA vaccine expressing a virus-like particle spike antigen against SARS-CoV-2Jason P Laliberte, Yingyun Cai, Tara Kenny, et al.
Pageof 9